Clorox appoints Fabian Garcia as CEO, succeeding Linda Rendle
The Clorox Company announced that Fabian Garcia, currently president of Unilever Personal Care, will become chief executive officer on January 5, 2027, replacing Linda Rendle. Rendle will remain chair and serve as an adviser through April 2, 2027. Matthew Shattock, the lead independent director, will assume the role of independent chair. The company will report its fiscal‑2027 first‑quarter results on November 2, 2026.
Why it matters
The leadership transition gives investors a clear timeline for when the new CEO will take charge and when the former CEO will step back, which may affect strategic direction and execution. The disclosed compensation package – a $100,000 base salary, $2 million annual bonus and a $4.55 million long‑term award – provides insight into the cost of the change.
Key facts
- 1Fabian Garcia will become CEO effective January 5, 2027. stocktitan.net
- 2Garcia succeeds Linda Rendle, who will remain chair and adviser until April 2, 2027. stocktitan.net
- 3Matthew Shattock will become independent chair on the same date. stocktitan.net
- 4Garcia’s compensation includes a $100,000 base salary, $2 million annual bonus and a $4.55 million long‑term award. tradingview.com
- 5Rendle’s current base salary of $1.35 million will continue through her advisory period. tradingview.com
- 6Clorox shares rose 1.89% in pre‑market trading following the announcement. rttnews.com
Summary written by AlphAI AI Desk from 8 of 8 sources. Not investment advice. Figures are as stated by the linked sources.